| |
| |
|
| Insider
Information: |
Scheller Richard H |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
381,640 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,916,677 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
381,640 |
|
|
| Total
Value |
$1,916,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
19
|
|
Stock
price went up :
|
0
|
11
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.4
|
| Percentage
Gain/Loss : |
0.0%
|
 -157.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenon Pharmaceuticals Inc. |
XENE |
Director |
2017-08-10 |
7,000 |
2017-08-10 |
0 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2023-02-16 |
53,822 |
2019-07-01 |
0 |
Premium* |
|
|
Alector, Inc. |
ALEC |
|
2023-07-15 |
44,250 |
2020-02-04 |
0 |
Premium* |
|
|
Oric Pharmaceuticals, Inc. |
ORIC |
Director |
2021-05-24 |
39,092 |
|
0 |
Premium* |
|
|
Dice Therapeutics, Inc. |
DICE |
Director |
2023-08-09 |
0 |
|
0 |
Premium* |
|
|
23andMe Holding Co. |
ME |
Director |
2023-09-06 |
237,476 |
2021-09-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2020-04-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
| DICE |
Dice Therapeutics, Inc. |
Director |
– • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
113,000 |
|
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
163,427 |
163,427 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2020-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
0 |
- |
|
| ME |
23andMe Holding Co. |
Director |
– • – |
2021-09-14 |
4 |
A |
$0.00 |
$0 |
D/D |
18,421 |
18,421 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2022-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,195 |
49,055 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Director |
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
9,459 |
9,459 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,196 |
50,941 |
0 |
- |
|
| ME |
23andMe Holding Co. |
Director |
– • – |
2022-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
57,755 |
76,176 |
0 |
- |
|
| ME |
23andMe Holding Co. |
Director |
– • – |
2022-09-06 |
4 |
A |
$0.00 |
$0 |
D/D |
14,633 |
90,809 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2022-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,196 |
53,036 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,196 |
55,126 |
0 |
- |
|
| ALEC |
Alector, Inc. |
|
• • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
26,250 |
35,709 |
0 |
- |
|
| ALEC |
Alector, Inc. |
|
– • – |
2023-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,541 |
44,250 |
0 |
- |
|
| DICE |
Dice Therapeutics, Inc. |
Director |
– • – |
2023-08-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,427) |
0 |
0 |
- |
|
| ME |
23andMe Holding Co. |
Director |
– • – |
2023-09-06 |
4 |
A |
$0.00 |
$0 |
D/D |
165,088 |
237,476 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2017-08-10 |
4 |
B |
$2.85 |
$19,950 |
D/D |
7,000 |
7,000 |
2.39 |
- |
|
| ME |
23andMe Holding Co. |
Director |
– • – |
2022-11-11 |
4 |
S |
$3.24 |
$59,684 |
D/D |
(18,421) |
72,388 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2022-05-16 |
4 |
D |
$6.74 |
$8,829 |
D/D |
(1,310) |
47,745 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2022-11-16 |
4 |
D |
$9.64 |
$10,662 |
D/D |
(1,106) |
51,930 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Director |
– • – |
2021-08-05 |
4 |
OE |
$10.14 |
$570,476 |
D/D |
56,260 |
56,260 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2022-08-16 |
4 |
D |
$11.08 |
$12,199 |
D/D |
(1,101) |
49,840 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-02-16 |
4 |
D |
$12.64 |
$16,483 |
D/D |
(1,304) |
53,822 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2020-12-15 |
4 |
OE |
$17.00 |
$497,709 |
D/D |
29,277 |
167,704 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2021-08-04 |
4 |
OE |
$17.00 |
$234,209 |
D/D |
13,777 |
59,637 |
0 |
- |
|
45 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
